Prema L. Mallipeddi

Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer

Elizabeth A. McMillan, Myung‐Jeom Ryu, Caroline H. Diep et al. · Cell · 2018 · 147 citations · Full text

Medicine, Chemistry, Oncology +14

HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress

Brandt A. Nichols, Nathaniel W. Oswald, Elizabeth A. McMillan et al. · Cancer Research · 2018 · 67 citations · Full text

Medicine, Molecular Biology, Oncology +17

Design and synthesis of cis-restricted benzimidazole and benzothiazole mimics of combretastatin A-4 as antimitotic agents with apoptosis inducing ability

Md. Ashraf, Thokhir Basha Shaik, M. Shaheer Malik et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Novel Molecular Interactions of Acylcarnitines and Fatty Acids with Myoglobin

Sree V. Chintapalli, Srinivas Jayanthi, Prema L. Mallipeddi et al. · Journal of Biological Chemistry · 2016 · 29 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase

Sarah E. Winterton, Emanuela Capota, Xiaoyu Wang et al. · Journal of Medicinal Chemistry · 2018 · 26 citations · Full text

Life Sciences, Oncology, Pharmacology +17